Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981474 · ClinicalTrials.gov registry record · NA
Cerebral Autoregulation Monitoring During Cardiac Surgery
A NA study of Cardiopulmonary Bypass and Thoracic Surgery, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 460
- Enrollment target
- 1
- Study location
NCT00981474 is a NA study of Cardiopulmonary Bypass and Thoracic Surgery that has completed, run by Northwestern University. The registered enrollment target is 460 participants, below the 693-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00981474, a NA study of Cardiopulmonary Bypass and Thoracic Surgery, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
- 1
- Study location
Study Summary
Neurological complications from cardiac surgery are an important source of operative mortality, prolonged hospitalization, health care expenditure, and impaired quality of life. New strategies of care are needed to avoid rising complications for the growing number of aged patients undergoing cardiac surgery. This study will evaluate novel methods for reducing brain injury during surgery from inadequate brain blood flow using techniques that could be widely employed.
Conditions Studied
Interventions
- DRUG blood pressure maintenance based on cerebral blood flow autoregulation measurement
- DEVICE Control group
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2009-09-01 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981474
The ClinicalTrials.gov registry entry for NCT00981474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 693-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (34% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiopulmonary Bypass appearing as the primary indexed condition, and to 2 interventions - of which blood pressure maintenance based on cerebral blood flow autoregulation measurement is the first listed.
NCT00981474 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00981474 about?
NCT00981474 is a clinical study titled "Cerebral Autoregulation Monitoring During Cardiac Surgery". Neurological complications from cardiac surgery are an important source of operative mortality, prolonged hospitalization, health care expenditure, and impaired quality of life. New strategies of care are needed to avoid rising complications for the growing number of aged patients undergoing cardiac...
What is the current status of trial NCT00981474?
This trial is currently completed. It is a NA study. The enrollment target is 460 participants. The study started on 2009-09-01. Estimated completion is 2020-02-28.
What conditions does trial NCT00981474 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass, Thoracic Surgery.
What interventions are being tested in trial NCT00981474?
The interventions under investigation include: blood pressure maintenance based on cerebral blood flow autoregulation measurement (DRUG), Control group (DEVICE).
Who is sponsoring clinical trial NCT00981474?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00981474 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Bypass
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
COMPLETED · NA
-
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
RECRUITING
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
-
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.